Old Web
English
Sign In
Acemap
>
authorDetail
>
Camille Lucidarme
Camille Lucidarme
Therapeutic drug monitoring
Infliximab
De-escalation
Diabetes mellitus
Medicine
2
Papers
45
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetic parameters of infliximab influence the rate of relapse after de‐escalation in adults with inflammatory bowel diseases
2019
Clinical Pharmacology & Therapeutics
Antoine Petitcollin
C. Brochard
L. Siproudhis
Camille Tron
Marie Clémence Verdier
Florian Lemaitre
Camille Lucidarme
Guillaume Bouguen
Eric Bellissant
Show All
Source
Cite
Save
Citations (20)
Predictors of relapse following infliximab de‐escalation in patients with inflammatory bowel disease: the value of a strategy based on therapeutic drug monitoring
2019
Alimentary Pharmacology & Therapeutics
Camille Lucidarme
Antoine Petitcollin
C. Brochard
L. Siproudhis
Marie Dewitte
Amandine Landemaine
Eric Bellissant
Guillaume Bouguen
Show All
Source
Cite
Save
Citations (25)
1